Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al. · New England Journal of Medicine · 2008 · 12.8K citations · Full text

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen et al. · The Lancet Oncology · 2008 · 5.8K citations

Hepatology, Medicine, Cancer Management +12

Sorafenib in Advanced Hepatocellular Carcinoma

재연 정 · 2008 · 5.6K citations

Hepatology, Medicine, Pathology +5

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

Journal of Hepatology · 2012 · 5.2K citations

Hepatology, Medicine, Histopathology +5

EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer

Josep M. Llovet, Michel Ducreux, Riccardo Lencioni et al. · 2012 · 1.5K citations

European Organisation, Hepatic Disorders, Hepatology +11